NEW YORK, Sept. 10 - Genops Bioinformatics signed an exclusive sales and marketing arrangement with Samsung Corp. for the Asia/Oceania market, the company announced Monday.
Under the partnership, Samsung Corp. will spearhead sales, marketing, and customer relations for Genops’ Ngene bioinformatics platform in the region. Samsung will also provide high-performance hardware and consulting services under the collaboration. Genops, based in Vancouver, BC, Canada, said the companies would share responsibility for ongoing product trials and administration.
Han Yu, president of Genops, said a revenue-sharing model is in place “that serves both companies well.” Further financial terms of the agreement were not disclosed.
Samsung’s prominent position in the Asia information technology market “will serve as a springboard for future product development and growth strategies in the area,” Yu said in a statement.
Last week, Genops announced a partnership with bioinformatics infrastructure provider Zerosum of Seven Valleys, Penn., to support the access, infrastructure, and delivery of Ngene.